Daniel Baker, M.D., will join Cue Biopharma's executive team as interim chief development officer (CDO), effective Monday, November 25, 2024Anish Suri, Ph.D., president & chief scientific officer (CSO ...

Anish Suri, Ph.D., president & chief scientific officer (CSO) of Cue Biopharma, to transition to principal research and immunology advisor BOSTON, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc.

People with chronic kidney disease, type 2 diabetes, or both of these conditions may have a higher cardiovascular disease ...

Two outpatient clinics in Foxborough that were expected to close last week have gained a new owner and remain open, marking ...

Although AI has the potential to improve and transform health care, doctors aren’t likely to leave the decision-making to ...

Some signs indicate efforts like the ones in Boston could be helping.

Cardiologists from BIDMC, commissioned by the FDA, examined trends in the use and long-term safety of a device for treating ...

A fifth company will be offering health insurance to eligible individuals in New Hampshire in 2025 as the state enters the ...

The question is more urgent as over-the-counter continuous glucose monitoring devices become more widely available.

More people in rural America are dying from heart disease, a new study says.Heart disease deaths increased among 25- ...

She received her bachelor of science degree in nursing at the University of Massachusetts Amherst and her master of business administration at Boston University. Her previous leadership experience ...